Goldberg Mark Alan bought IMGN
December 29, 2023 · Form 4 insider transaction
Goldberg Mark Alan bought 569 shares of ImmunoGen, Inc. at $29.65 per share, a transaction worth $16.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
569
Price
$29.65
Total value
$16.9K
InsiderGoldberg Mark Alan
RoleDirector
CompanyImmunoGen, Inc. (IMGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 29, 2023
Filing dateJanuary 3, 2024
Shares owned after60,720
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of common stock issued pursuant to the Compensation Policy for Non-Employee Directors as amended June 14, 2023 in lieu of cash compensation for services performed for the quarter ended December 31, 2023.